Rationale for Use of an FDA-Cleared Delivery System for Administration of Inhaled Nitric Oxide in Patients Undergoing Magnetic Resonance Imaging
Keyword(s):
Keyword(s):
2013 ◽
2008 ◽
Vol 79
(5)
◽
pp. 760-767
◽
2009 ◽
Vol 44
(2)
◽
pp. 67-73
◽
Keyword(s):